Ocular graft-versus-host disease (oGvHD) manifests in 60-80% of patients undergoing allogeneic haematopoietic stem cell transplantation, due to donor T cells incorrectly identifying recipient tissue as foreign, leading to an immunological attack by the donor cells1.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
